Back to search

Freie Universität Berlin

VCP Inhibition as a Targeted Therapy for Autosomal Dominant Polycystic Kidney Disease (ADPKD): Unveiling the Role of VCP as a Ciliary Protein in ADPKD

Abstract

dc:description.abstract

Autosomal dominant polycystic kidney disease (ADPKD) is a hereditary disorder characterized by progressive renal cyst development, leading to kidney enlargement and renal failure. The causative genes of ADPKD, Pkd1 and Pkd2, encode for the ciliary protein PC1 and PC2, positioning ADPKD in the ciliopathy spectrum. In this study, we investigated valosin-containing protein (VCP)'s role as a ciliary protein and its impact on ciliary assembly and morphology. In addition, we aimed to elucidate if VCP inhibition may hold therapeutic potential in specifically targeting cyst-lining cells in ADPKD. Our findings revealed that VCP colocalized with the ciliary marker ARL13B, supporting its presence in primary cilia. Prior to treatment, Pkd1-deficient cells exhibited significantly elongated primary cilia, consistent with dysregulated ciliary dynamics in ADPKD. The pharmacological inhibition of VCP (CB5083) markedly reduced the length of the elongated cilia structures found in cyst-lining cells. Furthermore, upon VCP inhibition, Pkd1-deficient cells showed a selective decrease in viability explained by upregulated UPR-mediated apoptosis. More importantly, in vivo, CB5083 treatment significantly reduced kidney-to-body-weight ratio, cystic index, and serum creatinine levels, and it also shortened cilia length. This in vivo approach demonstrates a protective effect against cystogenesis and reinforces the therapeutic potential of VCP inhibition. This study identifies VCP as a ciliary protein and points out its role in proteostasis and cystogenesis in ADPKD. The elongated cilia of Pkd1-deficient cells were significantly shortened upon VCP inhibition, suggesting an association between VCP activity and ciliary morphology. Together with the well-known role of aberrant ciliary signaling in cystogenesis, these findings support the concept that targeting cilia dynamics may represent a novel therapeutic strategy for ADPKD. Additionally, the selective induction of UPR-mediated apoptosis in Pkd1-deficient cells further underscores the potential of VCP inhibition as a targeted treatment approach.

Degree

thesis:*
Department dc:contributor.department
Charité - Universitätsmedizin Berlin
Year dc:date.issued
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Pioppini, Carlotta
Committee members dc:contributor.committeemember
  • N.N
  • N.N.

Subjects

dc:subject × 4

Rights

dc:rights.accessrights
Statement dc:rights.accessrights
  • open access
Language dc:language
eng

Identifiers

dc:identifier.*
URN
urn:nbn:de:kobv:188-refubium-52257-0

Chain of custody

source
Harvested from
Freie Universität Berlin
Base URL
refubium.fu-berlin.de/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Pioppini, Carlotta. VCP Inhibition as a Targeted Therapy for Autosomal Dominant Polycystic Kidney Disease (ADPKD): Unveiling the Role of VCP as a Ciliary Protein in ADPKD. 2026. https://refubium.fu-berlin.de/handle/fub188/52257